A novel monospecific tetravalent IgG1-(scFv)<sub>2</sub> version shown enhanced neutralizing and Fc-mediated effector functions against SARS-CoV-2.
- Published in:
- 3 Biotech, 2023, v. 13, n. 8, p. 1, doi. 10.1007/s13205-023-03702-z
- By:
- Publication type:
- Article